Scaffold and growth factor selection in temporomandibular joint disc engineering
Scaffold and growth factor selection in temporomandibular joint disc engineering
复制标题
DOI:
10.1177/154405910808700205
复制
发表时间:
2008-02-01
影响因子:
7.6
通讯作者:
Athanasiou, K. A.
中科院分区:
文献类型:
--
作者:
Allen, K. D.;Athanasiou, K. A.
Temporomandibular joint disc tissue-engineering studies commonly fail to produce significant matrix before construct contraction. We hypothesized that poly-L-lactic acid (PLLA) non-woven meshes would limit contraction, allow for comprehensive mechanical evaluation, and maintain viability relative to polyglycolic acid (PGA) non-woven mesh controls. Additionally, we proposed that growth factor stimulation, while limiting contraction, would increase construct properties relative to previous reports. After 4 wks, cell proliferation and matrix deposition were similar between the two meshes, but PGA constructs had contracted significantly. Furthermore, only PLLA constructs could be tested in tension and compression. Additional PLLA constructs were formed, then treated with insulin-like growth factor-1 (10 ng/mL), transforming growth factor-beta 1 (5 ng/mL), or transforming growth factor-beta 3 (5 ng/mL). Transforming growth factor-beta 1 yielded the most cells, collagen, and glycosaminoglycans at 6 wks; these constructs also demonstrated improved mechanics. Analysis of these data demonstrated significant temporomandibular joint discengineering potential for PLLA and transforming growth factor-beta 1.